Efficacy and Safety Results of Guselkumab in Patients With Active Psoriatic Arthritis Over 56 Weeks From a Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study
Document Type
Abstract
Publication Date
October 2017
Journal Title
Arthritis & Rheumatology
Department
Dermatology
Recommended Citation
Deodhar, A., Gottlieb, A., Boehncke, W., Dong, B., Wang, Y., Zhuang, Y., Barchuk, W., Xu, X., & Hsia, E. (2017). Efficacy and Safety Results of Guselkumab in Patients With Active Psoriatic Arthritis Over 56 Weeks From a Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study. Arthritis & Rheumatology, 69 (Suppl. 10), 2878. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/26
COinS
